Non-endoscopic Brushing of the Esophagus Using a Non-endoscopic Inflatable Balloon of the Esophagus in Screening for Barrett Esophagus
NCT02451124 is an interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barrett Esophagus. The registry lists an enrollment of 156 participants at 2 sites in 1 country. The registry lists a start date of 31 Jul 2015 and a primary completion date of 11 Aug 2016. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02451124 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Case Comprehensive Cancer Center |
| Enrollment | 156 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Barrett Esophagus |
| Start | 31 Jul 2015 |
| Primary completion | 11 Aug 2016 |
| Study completion | 29 Jan 2017 |
| Last update posted | 6 Nov 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02451124
Each answer restates registry values shown on this page.
What is NCT02451124?
NCT02451124 is an interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barrett Esophagus.
Who leads NCT02451124?
The registry names Amitabh Chak (principal investigator, Case Comprehensive Cancer Center) as the overall official.
Where does NCT02451124 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT02451124 end?
The registry lists a primary completion date of 11 Aug 2016 and a study completion date of 29 Jan 2017. The sponsor last updated the record on 6 Nov 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.